TOPICS: Class III antiarrhythmics, potassium channel blockers, phase 3, prolong repolarization, increase qt, increase erp, amiodarone, lipophilic, ibutilide, dofetilide, sotalol, atrial fibrillation, atrial flutter, ventricular tachycardia, rate control, torsades de pointes, beta blockade, bradycardia, inotropy, pulmonary fibrosis, hepatotoxicity, hyperthyroidism, hypothyroidism, corneal deposits, blue gray skin deposits, photodermatitis, neurologic effects, ataxia, peripheral neuropathy, constipation, bradycardia, heart block, heart failure, pulmonary function tests, thyroid function tests, liver function
